Minaprine Hydrochloride

CHEMBL1364551 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
371.3 g/mol
LogP
Phase
4

A hydrochloride salt form of minaprine, a psychostimulant and antidepressant previously used in Europe to treat depression and cognitive decline. It was withdrawn due to a risk of seizures at higher doses.

Moleküler Ağırlık

371,3000 g/mol

TPSA

50,30 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl

InChI

InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H

Molecular Formula

C17H24Cl2N4O

HBD / HBA

3 / 5

Döndürülebilir Bağlar

5

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt form of minaprine, a psychostimulant and antidepressant previously used in Europe to treat depression and cognitive decline. It was withdrawn due to a risk of seizures at higher doses.

Yes, Minaprine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1364551. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 33254. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.